Spectral Medical Sponsored Webinar: Endotoxin, The Phantom Menace of Sepsis

Spectral Medical Sponsored Webinar: Endotoxin, The Phantom Menace of Sepsis

4.6 (5 votes)

Webinar Description: 

What part does endotoxin play in the etiology of sepsis and septic shock? This sponsored webinar will describe the human response to elevated levels of endotoxin, both as an adaptive immune response and also as a trigger of sepsis. The ability to measure endotoxin activity in the bloodstream allows clinicians to uncloak its true prevalence and closely examine when endotoxin plays a role in sepsis. Can targeting endotoxin removal be a successful treatment modality for sepsis? Tune in to this webinar to learn more.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor: 

Sepsis Alliance gratefully acknowledges the support provided by Spectral Medical for this sponsored webinar.

image


Debra Foster, BSc

Clinical Consultant

Spectral Medical

Debra M. Foster, BSc, spent 11 years as an RN in the adult critical care area. Thereafter, Debra joined the critical care clinical research team at Toronto General Hospital. She was project lead for a multi-national, multi-center clinical trial - the MEDIC study. The data was used for a successful 510(k) de novo submission to the FDA for the Endotoxin Activity Assay (EAA). It was the first IVD for sepsis. Debra went on to follow the device to its commercial partner, Spectral Medical, Inc. She became VP of Clinical Development in 2011.  Debra led many clinical research projects, including the MEDIC, EUPHRATES, and TIGRIS clinical trials, aimed at endotoxin in critical illness. Currently, Debra is a clinical consultant for Spectral Medical. She has lectured to medical professionals on the topics of sepsis, endotoxin, and clinical trials for sepsis and has been a co-author of more than 50 articles in peer-reviewed journals.  

Mark A. Tidswell, MD

Professor of Medicine

UMASS Chan Medical School – Baystate

Mark A. Tidswell, MD, is a Professor of Medicine at UMASS Chan Medical School – Baystate. Trained asa pulmonary and critical care physician, his clinical practice is adult critical care and neurocritical care at Baystate Medical Center in Springfield, MA. He began work in multi-center clinical trials 25 years ago. He was an active contributor to the NHLBI research networks ARDSnet and PETAL from 2000 – 2024, which studied thousands of patients with ARDS, sepsis, and COVID-19. He serves as site PI for pharmaceutical trials in the area of sepsis and ARDS and has 20 years of experience using the Endotoxin Activity Assay to identify endotoxemia in patients in clinical trials. Dr. Tidswell was an investigator in the EUPHRATES trial and is part of the scientific steering committee for the TIGRIS study. He is a co-author and contributor to more than 90 publications.

Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.

Components visible upon registration.